As it gets easier to engineer deadly pathogens, the International Biosecurity and Biosafety Initiative for Science wants tighter controls on custom-order DNA companies, and an end to the current ‘checkbox’ approach to lab safety
The crash of the FTX cryptocurrency exchange drew attention to a growing movement in the tech world aiming to become better at predicting, steering and sequencing scientific breakthroughs. The notion is gaining traction in Europe and the US – scandal notwithstanding
The UK can play a global role in R&D and whilst remaining involved in EU programmes said George Freeman, setting out plans to attract foreign capital into the research ecosystem
Research commissioner Mariya Gabriel has linked re-admittance to ESFRI to wider relations between the EU and Switzerland. Some see this as a sign the body is too heavily controlled by the Commission
Despite hosting CERN, the country is being excluded from ESFRI because it has not associated to Horizon Europe. Swiss scientists call the decision “unreasonable”
The agency wants to give individual reviewers the power to fund proposals they think are promising, even if other panellists disagree. The aim is to avoid only backing the least controversial applications
But 213 researchers chose to stay put, giving up their awards. These have now been reallocated. Meanwhile, the UK has extended its safety net for ERC grant winners
On a visit to Japan, science minister George Freeman unveiled the latest funding pot designed to compensate for exclusion from Horizon Europe. But he insists association to the EU’s framework programme remains the UK’s first choice
Blanket subsidies to generate hydrogen in the US are already tempting European producers to set up manufacturing sites across the Atlantic. The issue became a flashpoint in recent negotiations between Washington and Brussels
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.